EP1254269A4 - Methods and materials relating to neuronal guidance molecule-like (ngm-like) polypeptides and polynucleotides - Google Patents

Methods and materials relating to neuronal guidance molecule-like (ngm-like) polypeptides and polynucleotides

Info

Publication number
EP1254269A4
EP1254269A4 EP01908837A EP01908837A EP1254269A4 EP 1254269 A4 EP1254269 A4 EP 1254269A4 EP 01908837 A EP01908837 A EP 01908837A EP 01908837 A EP01908837 A EP 01908837A EP 1254269 A4 EP1254269 A4 EP 1254269A4
Authority
EP
European Patent Office
Prior art keywords
ngm
polynucleotides
polypeptides
methods
materials relating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01908837A
Other languages
German (de)
French (fr)
Other versions
EP1254269A1 (en
Inventor
Bryan J Boyle
George Yeung
Matthew C Arterburn
Chenghua Liu
Y Tom Tang
Shubhada D Godbole
Chiaoyun Kuo
Radoje T Drmanac
Sereando Palencia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nuvelo Inc
Original Assignee
Nuvelo Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nuvelo Inc filed Critical Nuvelo Inc
Priority to EP05005504A priority Critical patent/EP1574520A3/en
Publication of EP1254269A1 publication Critical patent/EP1254269A1/en
Publication of EP1254269A4 publication Critical patent/EP1254269A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6432—Coagulation factor Xa (3.4.21.6)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21006—Coagulation factor Xa (3.4.21.6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EP01908837A 2000-02-03 2001-02-02 Methods and materials relating to neuronal guidance molecule-like (ngm-like) polypeptides and polynucleotides Withdrawn EP1254269A4 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP05005504A EP1574520A3 (en) 2000-02-03 2001-02-02 Methods and materials relating to neuronal guidance molecule-like (NGM-like) polypeptides and polynucleotides

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US49691400A 2000-02-03 2000-02-03
US496914 2000-02-03
US56087500A 2000-04-27 2000-04-27
US560875 2000-04-27
US72111500A 2000-11-22 2000-11-22
US721115 2000-11-22
PCT/US2001/003661 WO2001057262A1 (en) 2000-02-03 2001-02-02 Methods and materials relating to neuronal guidance molecule-like (ngm-like) polypeptides and polynucleotides

Publications (2)

Publication Number Publication Date
EP1254269A1 EP1254269A1 (en) 2002-11-06
EP1254269A4 true EP1254269A4 (en) 2004-10-27

Family

ID=27414045

Family Applications (2)

Application Number Title Priority Date Filing Date
EP01908837A Withdrawn EP1254269A4 (en) 2000-02-03 2001-02-02 Methods and materials relating to neuronal guidance molecule-like (ngm-like) polypeptides and polynucleotides
EP05005504A Withdrawn EP1574520A3 (en) 2000-02-03 2001-02-02 Methods and materials relating to neuronal guidance molecule-like (NGM-like) polypeptides and polynucleotides

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP05005504A Withdrawn EP1574520A3 (en) 2000-02-03 2001-02-02 Methods and materials relating to neuronal guidance molecule-like (NGM-like) polypeptides and polynucleotides

Country Status (4)

Country Link
EP (2) EP1254269A4 (en)
AU (1) AU2001236663A1 (en)
CA (1) CA2399652A1 (en)
WO (1) WO2001057262A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2417349A1 (en) * 2000-07-28 2002-02-07 Curagen Corporation Novel proteins and nucleic acids encoding same
US7223558B2 (en) 2001-07-11 2007-05-29 Bristol-Myers Squibb Company Polynucleotides encoding three novel human cell surface proteins with leucine rich repeats and immunologobulin folds, BGS2, 3, and 4 and variants thereof
WO2004085648A2 (en) 2003-03-19 2004-10-07 Biogen Idec Ma Inc. Nogo receptor binding protein
AU2005258335B2 (en) 2004-06-24 2011-03-17 Biogen Ma Inc. Treatment of conditions involving demyelination
SG163591A1 (en) 2005-07-08 2010-08-30 Biogen Idec Inc Sp35 antibodies and uses thereof
US8128926B2 (en) 2007-01-09 2012-03-06 Biogen Idec Ma Inc. Sp35 antibodies and uses thereof
DK2982695T3 (en) 2008-07-09 2019-05-13 Biogen Ma Inc COMPOSITIONS CONCERNING ANTIBODIES AGAINST LINGO OR FRAGMENTS THEREOF
WO2013173364A2 (en) 2012-05-14 2013-11-21 Biogen Idec Ma Inc. Lingo-2 antagonists for treatment of conditions involving motor neurons
WO2016112270A1 (en) 2015-01-08 2016-07-14 Biogen Ma Inc. Lingo-1 antagonists and uses for treatment of demyelinating disorders

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999006427A1 (en) * 1997-08-04 1999-02-11 Millennium Biotherapeutics, Inc. Tango-78, tango-79, and tango-81 nucleic acid molecules and polypeptides
WO1999055865A1 (en) * 1998-04-29 1999-11-04 Genesis Research And Development Corporation Limited Polynucleotides isolated from skin cells and methods for their use
WO2000071584A1 (en) * 1999-05-20 2000-11-30 Human Genome Sciences, Inc. Seven transmembrane receptor genes
WO2001000638A2 (en) * 1999-06-29 2001-01-04 Millennium Pharmaceuticals, Inc. Novel genes encoding proteins having diagnostic, preventive, therapeutic, and other uses

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5320700A (en) * 1999-06-04 2000-12-28 Millennium Pharmaceuticals, Inc. Novel toll molecules and uses therefor
CA2417349A1 (en) * 2000-07-28 2002-02-07 Curagen Corporation Novel proteins and nucleic acids encoding same
WO2002024733A2 (en) * 2000-09-15 2002-03-28 Curagen Corporation Human polynucleotides and polypeptides encoded thereby

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999006427A1 (en) * 1997-08-04 1999-02-11 Millennium Biotherapeutics, Inc. Tango-78, tango-79, and tango-81 nucleic acid molecules and polypeptides
WO1999055865A1 (en) * 1998-04-29 1999-11-04 Genesis Research And Development Corporation Limited Polynucleotides isolated from skin cells and methods for their use
WO2000071584A1 (en) * 1999-05-20 2000-11-30 Human Genome Sciences, Inc. Seven transmembrane receptor genes
WO2001000638A2 (en) * 1999-06-29 2001-01-04 Millennium Pharmaceuticals, Inc. Novel genes encoding proteins having diagnostic, preventive, therapeutic, and other uses

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
See also references of WO0157262A1 *
WANG KUAN HONG ET AL: "Biochemical purification of a mammalian Slit protein as a positive regulator of sensory axon elongation and branching", CELL, vol. 96, no. 6, 19 March 1999 (1999-03-19), pages 771 - 784, XP002273837, ISSN: 0092-8674 *

Also Published As

Publication number Publication date
EP1574520A3 (en) 2005-12-21
AU2001236663A1 (en) 2001-08-14
EP1574520A2 (en) 2005-09-14
WO2001057262A1 (en) 2001-08-09
EP1254269A1 (en) 2002-11-06
CA2399652A1 (en) 2001-08-09

Similar Documents

Publication Publication Date Title
HUP0102535A3 (en) Cd19xcd3 specific polypeptides and uses thereof
EP1250346A4 (en) Methods and materials relating to g protein-coupled receptor-like polypeptides and polynucleotides
EP1252333A4 (en) Methods and materials relating to cd84-like polypeptides and polynucleotides
GB2327531B (en) Ion mobility spectrometer in a centripetal arrangement
EP1254269A4 (en) Methods and materials relating to neuronal guidance molecule-like (ngm-like) polypeptides and polynucleotides
GB9726294D0 (en) Improvements relating to hand held devices
EP1254266A4 (en) Methods and materials relating to alpha-2-macroglobulin-like polypeptides and polynucleotides
EP1049708A4 (en) Meth1 and meth2 polynucleotides and polypeptides
GB2367431B (en) Multi-axis potentiometer
GB9707743D0 (en) Analysis
GB9712694D0 (en) Improvements in and relating to compounds,sensors and extractants
AU3486501A (en) Methods and materials relating to alpha-2-macroglobulin-like polypeptides and polynucleotides
GB9824279D0 (en) Spectroscopic analysis
EP1254265A4 (en) Methods and materials relating to metallocarboxypeptidase-like polypeptides and polynucleotides
AU2002359351A8 (en) Methods and materials relating to prokineticin-like polypeptides and polynucleotides
GB0031021D0 (en) Polynucleotides and polypeptides
EP1261736A4 (en) Methods and materials relating to preadipocyte factor-1-like (pref-1-like) polypeptides and polynucleotides
EP1409715A4 (en) Methods and materials relating to neurotrimin-like polypeptides and polynucleotides
EP1276902A4 (en) Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides
AU2001294267A1 (en) Survivin-like polypeptides and dnas thereof
AU7005801A (en) Gp354 nucleic acids and polypeptides
EP1242580A4 (en) Methods and materials relating to semaphorin-like polypeptides and polynucleotides
AU2001231288A1 (en) Methods and materials relating to matrix metalloprotease-like polypeptides and polynucleotides
GB9718664D0 (en) Improvements in or relating to capsules
GB0018700D0 (en) Polynucleotides and polypeptides

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020827

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NUVELO INC.

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NUVELO, INC.

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 07K 14/47 A

A4 Supplementary search report drawn up and despatched

Effective date: 20040913

17Q First examination report despatched

Effective date: 20050110

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20050503